Europe Surgical Robots Market

The Europe surgical robots market is projected to reach USD 5.21 billion by 2031 from USD 2.38 billion in 2025, at a CAGR of 14.0% during the forecast period.

The Europe market for surgical robots is experiencing rapid growth, the reasons for this being several interrelated factors. The biggest driver is the rising demand for minimally invasive surgeries. Patients and healthcare systems, as a result of the advantages offered by such procedures, smaller incisions, fewer complications, shorter hospital stays, and quicker recovery times, are choosing those methods more and more, and robotic systems can deliver these results more consistently than traditional surgery. The aging population and growing prevalence of chronic diseases, such as cancer, cardiovascular conditions, and orthopedic issues, among others, are leading to an increase in complex surgical procedures in which robots can offer clinical advantages, for instance, enhanced precision and improved postoperative outcomes. The introduction of new technologies and the creation of next-generation robotic platforms, being compact, modular, and more affordable systems with better visualization, dexterity, and AI-assisted features, are opening new clinical applications and lowering the adoption barriers.

To know about the assumptions considered for the study download the pdf brochure

Some of the prominent players operating in the market include Intuitive Surgical (US), Stryker(US), Medtronic (Ireland), Smith+Nephew (UK), Zimmer Biomet (US), among other players.

The‍‌ most prominent surgical robotics firms in Europe are strengthening their positioning in the market through continuous innovation, expanding their reach across the region, and forming collaborations that are strategically beneficial to them. The company's R&D budgets are heavily loaded with the development of the next-generation robotic platforms featuring even better imaging, AI-enabled guidance, and improved ergonomics for the sake of enhancing surgical precision and making the operating room more efficient. To spread market penetration more deeply throughout Europe, the major players have aggressively embarked on a partnership and acquisition strategy to broaden procedure coverage, facilitate the integration of robots into hospital networks, and create new care setting access, such as ambulatory surgery centers. The main aim of these collaborations is to stimulate surgeon adoption and create strong installed-base ecosystems. In most cases, such agreements include training collaborations with university hospitals and surgical societies, which, in turn, lead to rapid surgeon adoption and consolidated installed-base ‍‌ecosystems.

In July 2025, Intuitive‍‌ Surgical’s newest system, da Vinci 5, was granted the CE mark in Europe for minimally invasive procedures in both adults and children, thus indicating its regulatory debut in the European market with additional features aimed at increasing the precision and the surgeon's ‍‌comfort.

In May 2025, the FDA’s approval of the da Vinci Single-Port system for transanal local excision marks a significant step in expanding robotic capabilities in colorectal surgery. By enabling natural-orifice access for lesion removal and excision procedures, the system reduces the need for external incisions, leading to less tissue trauma, reduced scarring, and faster postoperative recovery. This clearance increases the clinical value of the SP platform and widens its use across soft-tissue procedures.

In April 2025, CMR‍‌ Surgical secured more than USD 200 million in capital to fasten the global market rollout of its Versius Surgical Robotic System, aid product development (including Versius Plus), and finance clinical trials in the areas of pediatric and transoral ‍‌surgery.

Intuitive Surgical (US)

Intuitive Surgical is at the forefront of the European surgical robotics industry. The‍‌ firm is known for pioneering and delivering robotic-assisted minimally invasive surgery to the market. Its flagship product, the da Vinci Surgical System, is essentially a tool that allows surgeons to perform complex operations with greater accuracy, control, and visualization. Moreover, Intuitive's product portfolio includes future-generation robotic platforms, surgical instruments, and accessories, along with the training programs that facilitate surgeons' acquiring proficiency. Intuitive's overwhelming hold on the market can be traced back to its clinical performance over time, a comprehensive surgeon training environment, and the strong binding of its systems with hospital ‍‌workflows. The company commits to innovation continuously, aiming at better ergonomics, imaging, and digital features to open new possibilities for robotic procedures. Intuitive, with its wide global reach and a vast installed base, enjoys very high customer loyalty and recurring revenue from instrument usage and service offerings. At the same time, it keeps on developing new specialties and applications of robotic ‍‌surgery.

Stryker (US)

Stryker‍‌ Corporation is one of the leading companies in the Europe surgical robotics market, especially in orthopedics, through its Mako SmartRobotics platform. As a result of the purchase of Mako Surgical in 2013, Stryker combined robotic-assisted joint replacement with its overall orthopedic ecosystem. The Mako platform is a combination of CT-based preoperative planning, haptic guidance, and intraoperative feedback that provides the operator with the ability to perform extremely accurate knee and hip replacement surgeries. Stryker's strategy not only merges robotics with the company's implant portfolio but also facilitates the clinical workflow and makes the therapeutic process more efficient for the patient in joint arthroplasty. By its new Mako 4, Stryker is extending the system to be capable of not only hip and knee but also spine and shoulder surgeries. And they are incorporating a next-generation guidance system that is grounded in their extensive experience in navigation. The company went on to say that it also puts a great deal of emphasis on the evidence-based method, its robotics business is supported by hundreds of peer-reviewed studies, proprietary data analytics, and continuous innovation to surgical teams ‍‌worldwide.

Market Ranking

The European surgical robots market is consolidated and primarily dominated by Intuitive Surgical. This is because of the largest installed base of da Vinci systems, high procedure volumes, and deep integration into hospital workflows in the major countries. One of the leading players in orthopedic robotics is Stryker, and its Mako platform is the most attractive for knee and hip replacement surgery in European joint-replacement centers. With the Hugo RAS system and its numerous hospital relationships, Medtronic is a very aggressive challenger who is going to new tender wins and footprint expansions. Zimmer Biomet is focusing next on ROSA Knee and ROSA Spine, which are, thus, becoming widely accepted in the orthopedic and spine surgery departments. ROSA- Knee and ROSA-Spine are the products of Zimmer Biomet, which is the next company, slowly gaining adoption in the orthopedic and spine surgery units. At present, Smith+Nephew has limited expansion potential with the CORI system, but is shaping itself as a future competitor in digital and orthopedic robotic surgery in ‍‌Europe.

Related Reports:

Europe Surgical Robots Market by Product (Instruments & Accessories, Robotic Systems [Laparoscopy, Orthopedic], Services), Application (Urological Surgery, Orthopedic Surgery), End User (Hospitals, Specialty Clinics, ASCs) - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com